The results showed that the signaling pathways associated with tumor occurrence and development, drug resistance, and angiogenesis, such as the mTOR signaling pathway, Notch signaling pathway, VEGF signaling pathway, and ABC transporters, were enriched to varying degrees in Cluster 2 patients with a poor prognosis. The gene discussed is ABCG2; the disease is neoplasm.